NCT03617003View on ClinicalTrials.gov

Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions
Upper Tract Urothelial Carcinoma
Interventions
DRUG

WST11 mediated vascular targeted phototherapy (VTP)

All patients will receive intravenous administration of WST11 at a dose of 4 mg/kg, infused over 10 minutes while patients are under anesthesia during their endoscopy procedure, followed by immediate laser light application.

PROCEDURE

Endoscopy

Endoscopy of the bladder

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03617003 - Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11) | Biotech Hunter | Biotech Hunter